Peptide-based Eye Drops Show Promise for Treating Age-Related Vision Loss
Scientists have developed a new Peptide-based eye drop treatment that could help people with age-related macular degeneration (AMD), a leading cause of vision loss in individuals over 65. AMD affects the macula, the central part of the retina responsible for sharp vision, leading to blurred or distorted sight. There are two types of AMD: dry…